Symkevi Euroopa Liit - saksa - EMA (European Medicines Agency)

symkevi

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - mukoviszidose - andere produkte für die atemwege - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Quetiapine Intas Pharmaceuticals 50 mg Retardtablette Belgia - saksa - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

quetiapine intas pharmaceuticals 50 mg retardtablette

intas pharmaceuticals - quetiapine fumarate - retardtablette - 50 mg - quetiapine fumarate 57.575 mg - quetiapine

Quetiapine Intas Pharmaceuticals 200 mg Retardtablette Belgia - saksa - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

quetiapine intas pharmaceuticals 200 mg retardtablette

intas pharmaceuticals - quetiapine fumarate - retardtablette - 200 mg - quetiapine fumarate 230.3 mg - quetiapine

Quetiapine Intas Pharmaceuticals 300 mg Retardtablette Belgia - saksa - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

quetiapine intas pharmaceuticals 300 mg retardtablette

intas pharmaceuticals - quetiapine fumarate - retardtablette - 300 mg - quetiapine fumarate 345.45 mg - quetiapine

Quetiapine Intas Pharmaceuticals 400 mg Retardtablette Belgia - saksa - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

quetiapine intas pharmaceuticals 400 mg retardtablette

intas pharmaceuticals - quetiapine fumarate - retardtablette - 400 mg - quetiapine fumarate 460.6 mg - quetiapine

Epidyolex Euroopa Liit - saksa - EMA (European Medicines Agency)

epidyolex

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptika, - epidyolex ist indiziert für den einsatz als zusatztherapie von anfällen verbunden mit lennox-gastaut-syndrom (lgs) oder dravet-syndrom (ds), in verbindung mit clobazam, für patienten, die 2 jahre und älter.